Cubist to buy Trius Therapeutics, Optimer Pharma for up to $1.62 billion
(Reuters) - Cubist Pharmaceuticals Inc said it would buy Trius Therapeutics Inc and Optimer Pharmaceuticals Inc for up to $1.62 billion to boost its a...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/z5DUZU51Mug/story01.htm
No comments:
Post a Comment